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THE EFFECT OF ELECTRONIC NICOTINE DELIVERY SYSTEMS ON THE 
VOCAL FOLDS 
HILARY SAMPLE 
ABSTRACT 
Electronic Nicotine Delivery Systems (ENDS) are non-combustible tobacco 
products that are rapidly gaining in popularity worldwide. ENDS are marketed as safer 
alternatives to cigarettes; however, very little research is available to support or deny 
these claims. ENDS aerosol is inhaled over the vocal folds and into the lungs consistent 
with cigarette smoke. The larynx is among the primary locations affected by smoking; 
therefore, it is necessary to evaluate the effect, if any, of ENDS on the larynx.  
 The goal of the present study was to evaluate the laryngeal appearance and 
function of seven ENDS users as compared to four cigarette smokers. A control group of 
six nonsmokers was included in this study. Vocal tasks were assessed through acoustic 
analysis and videostroboscopy. No significant relationship was found between ENDS use 
and abnormal acoustic measures; however, data compared to norms for age and gender 
revealed a pattern of raised shimmer percent among ENDS users and smokers. 
Videostroboscopic analysis revealed significant relationships between ENDS use and 
abnormal mucosal wave, free edge, phase closure, vocal fold varices and vocal fold 
edema, as well as a marginally significant relationship between ENDS use and abnormal 
phase symmetry. These results indicate that ENDS use may have a significant effect on 
laryngeal structures and their function. 
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CHAPTER I 
INTRODUCTION 
 
Electronic Nicotine Delivery Systems (ENDS), also termed electronic cigarettes, 
e-cigarettes, and e-cig, are non-combustible tobacco products that are rapidly gaining in 
popularity since their introduction into the global market in 2004.  ENDS are hand-held 
battery-powered devices that heat a solution, termed “e-liquid” to generate an aerosol, 
which is then inhaled.  ENDS were designed to substitute cigarettes by providing a 
similar physical and sensory experience to that of smoking (Asgharian, Price, Rostami & 
Pithawala, 2018; Chapman & Wu, 2014). ENDS is perceived as a safer alternative to 
cigarettes (Chapman & Wu, 2014); however, very few studies exist on the effects of 
ENDS use, and limited research is available to either prove or disprove these assertions.  
Following a puff, ENDS aerosol is delivered over the vocal folds and into the 
lungs. The remaining aerosol is exhaled back over the vocal folds, through the oral 
cavity, and into the environment (Cheng, 2014). The aerosol travels through the 
respiratory tract in the same manner as conventional cigarettes. The larynx, which is 
located in the upper respiratory tract, has been examined histologically, acoustically, and 
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perceptually to determine health effects after exposure to cigarette smoke. 
Researchers have found that the larynx, especially the true vocal folds, is the main site 
affected by inhalation of cigarette smoke (Auerbach, Hammond, & Garfinkel, 1970; 
Kelleher, Siegmund, & Chan, 2014).  
Numerous studies have been conducted that describe anatomical and 
physiological changes in the vocal folds and larynges of smokers that occurs as a result of 
smoking (Myerson, 1964; Auerbach et al., 1970; Awan & Morrow, 2007; Banjara, 
Mungutwar, Singh, & Gupta, 2011; Kelleher, Siegmund, & Chan, 2014; Öğüt & Kiliç, 
2013; Stanciu & Bennett, 1972).  It is reasonable to believe the same anatomical 
structures most impacted by cigarette smoke exposure may also be impacted by ENDS 
aerosol exposure. However, due to the recent availability of ENDS on the United States 
market, research is extremely limited on the effects of long-term chronic ENDS exposure 
on the larynx.  Therefore, evaluation of ENDS users’ laryngeal anatomy and physiology 
is necessary to assess the effects, if any, of ENDS on the human larynx.  
ENDS Devices  
ENDS devices have three basic parts: a rechargeable lithium battery, an atomizer, 
and a reservoir, cartridge or pod, which contains e-liquid. Activation of the heating coil 
within the atomizer transforms the e-liquid into nicotine aerosol (Kaisar, Prasad, Liles & 
Cucullo, 2016).  ENDS devices may have either an airflow sensor or a manual trigger 
that activates a heating coil. The heating coil raises the temperature of the atomizer, 
which produces an aerosol from the e-liquid. The aerosol is then puffed through a 
mouthpiece connected to the e-liquid cartridge (Figure 1.2). There are two types of 
ENDS: open and closed systems. These are also referred to as open and closed tank 
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respectively. The cartridge or tank is refillable in open system devices, and the cartridge 
is disposable and prefilled with e-liquid in closed system devices. 
The design, technical characteristics and operation of ENDS are rapidly evolving. 
Technical characteristics include the maximum battery output, temperature of the heat 
coil, and the ability to modify the device. Advances in technical characteristics over time 
differentiate devices into subtypes or “generations”.  The four main subtypes of ENDS 
devices include: disposable cigalike, rechargeable cigalike, rechargeable vaporizers, and 
rechargeable pod systems (Glasser et al., 2017).    
Disposable Cigalikes. Disposable cigalikes are single-use first-generation devices 
that closely resemble cigarettes, complete with a light emitting diode (LED) at the tip that 
is activated when a user inhales (Figure 1.1). These electronic cigarettes are neither 
rechargeable nor refillable. Disposable cigalikes are discarded in their entirety when e-
liquid is depleted. The low voltage battery is activated by an airflow sensor when the user 
inhales, which then activates the heating coil, resulting in aerosol production. 
 
 Figure: 1.1 Disposable/rechargeable cigalike components 
(From Choosing the Right Type of Electronic Cigarette (Vape). (2014, March 1). Retrieved January 13, 
2019, from Vaporferver website: https://vaporferver.com/electronic-cigarette-info/choosing-the-right-type-
of-electronic-cigarette/) 
 
Rechargeable cigalikes. Rechargeable cigalikes closely resemble disposable 
cigalikes but include a rechargeable battery (Figure 1.1). Rechargeable cigalikes are 
second generation devices that have two options: manual trigger or airflow sensor. With 
an airflow sensor, otherwise termed “automatic draw”, the battery is activated by 
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inhalation and requires a disposable cartomizer. A cartomizer is a combined unit for both 
the atomizer and pre-filled cartridge. The battery for manual trigger, also termed “manual 
draw”, is activated by pressing a button.       
Rechargeable vaporizers. Rechargeable vaporizers are third-generation devices 
that do not resemble cigarettes and include “vape pens” (Figure 1.2), “mods” and “box 
mods” (Figure 1.3).  These rechargeable devices are open tank systems. They are larger 
than cigalikes with modifiable, higher voltage batteries and more advanced atomizers. 
With refillable reservoirs, users have the option to customize e-liquid. These devices are 
either variable voltage or temperature controlled. Variable voltage devices have 
modifiable batteries, which allow the user to modify the device voltage and temperature 
of the coil. Increasing the temperature of the coil alters the density and “hit” of the 
aerosol, creating a similar physical sensation to cigarette smoke inhalation. 
 
Figure 1.2 Systematic illustration of rechargeable vape pen  
(From Kaisar et al., 2016) 
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Figure 1.3 schematic illustration of components of a “box mod” rechargeable vaporizer 
E-Cig 101 - Informative and Always Tuition Free! (n.d.). Retrieved January 13, 2019, from 
https://www.nicotinenirvana.com/ecig-101-s/12.htm 
 
Rechargeable pod systems. Rechargeable pod systems are current generation 
devices that come in a multitude of designs (Figure 1.4). These devices may be user-
modifiable, are rechargeable, and are either open tank or close tank systems. Devices may 
be variable voltage or temperature controlled.  Temperature controlled models allow the 
user to program a fixed temperature into the microchip for a consistent aerosol output. 
Rechargeable pods include brands like “Suorin Drop”, “myblu”, and “Juul”. 
     Juul has become its own category of vape devices and users, especially within the 
adolescent and 18-25-year old young adult population, who now replace the verb 
“vaping” with “juuling” (Huang et al., 2018).  The voltage of these devices is controlled 
application, meaning that users cannot modify voltage output. The amount of nicotine per 
e-liquid pod is approximately equivalent to one pack of cigarettes or 200 puffs (Kee, 
2018; Huang et al., 2018; Dawkins, Kimber, Puwanesarasa & Soar, 2015).  
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Figure 1.4 Rechargeable pod schematic illustration of juul components 
from King County - E-cigarettes and vaping products (n.d.). Retrieved January 13, 2019, from 
https://www.kingcounty.gov/~/media/depts/health/tobacco-vapor/images/juul-diagram-carousel.ashx 
 
ENDS Regulation and Standardization 
The U.S. Food and Drug Administration (FDA) has authority to regulate tobacco 
products, and in 2016, extended that regulatory authority to ENDS products; however, 
the ENDS industry has an extended deadline of 2022 to comply with new FDA 
guidelines (US Food and Drug Administration, 2016; Zare, Nemati & Zheng, 2018). Just 
as the FDA heavily regulates cigarettes, including flavor, nicotine levels, and the number 
of cigarettes per pack, it will potentially regulate ENDS attributes, including but not 
limited to flavors, nicotine strength, and e-liquid size and contents. At the present time, 
ENDS products are not standardized and are not yet required to conform to regulatory 
guidelines. Due to the lack of regulation and standardization of ENDS devices, e-liquids 
and devices with the same name and the same listed ingredients have shown 
inconsistencies in contents, including nicotine, when examined by researchers (Etter, 
Zather, & Svensson, 2013; Famele et al., 2015; Goniewicz et al., 2015; Goniewicz, 
Hajek, & McRobbie, 2014; Goniewicz, et al., 2014; Hahn et al, 2014; Lisko et al,  2016; 
Kaisar et al., 2016 ). 
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ENDS Toxicity  
ENDS e-liquid contains nicotine, a carrier liquid, such as vegetable glycerin and 
propylene glycol, and any number of flavoring agents that make up thousands of 
available flavors (Zhu, Sun, Bonnevie, Cummins, Gamst, Yin & Lee, 2014; Soussy, El-
Hellani, Baalbaki, Salman, Shihadeh & Saliba, 2016). Research on the chemical 
composition of ENDS e-liquid and aerosol has revealed substances that are known to be 
harmful in cigarette smoke (Kosmider et al, 2014; Fowels & Dybing, 2003). 
Additionally, toxicity of ENDS aerosol has been shown to increase relative to increased 
sweetener concentration and increased heat due to high battery voltage output (Kosmider 
et al, 2014).  
Toxins contained in e-liquids and aerosol. Research on the chemical 
composition of ENDS has found heavy metals, carcinogens and teratogenic agents, 
including carbonyl compounds, aldehydes, volatile organic compounds, and tobacco-
specific nitrosamines present in ENDS e-liquid and aerosol (Farsalinos et al., 2013; 
Tierney, Karpinski, Brown, Luo & Pankow, 2016; Kaisar et al., 2016).  The majority of 
ENDS contain vegetable glycerin and propylene glycol as carrier liquids. These 
substances are ‘generally recognized as safe’ (GRAS) by the Flavor Extracts 
Manufacturer’s Association (FEMA); however, this perception refers primarily to the 
effect of ingestion on the digestive tract. Chronic exposure of aerosolized forms of these 
substances may affect the airway differently. This may include reducing the consistency 
of fluid in the tissue or exposing the tissue of the airway to harmful toxins formed during 
the heating process (Callahan-Lyon, 2014; Kosmider, Sobczak, Fik, Knysak, Zaciera, 
Kurek, Goniewicz, 2014).  
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Propylene glycol and vegetable glycerin both thermally degrade to toxic carbonyl 
compounds (Laino, Tuma, Moor, Martin, Stolz & Curioni, 2012; Kosmider et al., 2014; 
IARC, 2012). Acetone and aldehydes, including formaldehyde, benzaldehyde, and 
acrolein, among others, found within ENDS aerosol are formed during the heating 
process (Kosmider et al., 2014).  Acetone is a known mucous membrane irritant (Buron, 
Hacquemand, Pourie, & Brand, 2009), and aldehydes and heavy metals have been shown 
to have cytotoxic effects on epithelium (Rowell & Taran, 2015). Formaldehyde is 
classified as a Group 1 human carcinogen by the International Agency for Research of 
Cancer, and acetaldehyde is classified as Group 2B, possibly carcinogenic to humans 
(IARC, 2012). Acrolein has been found to cause irritation in the nasal cavity and damage 
to pleural lining (U.S. EPA, 2003). Exposure to carbonyls causes mouth and throat 
irritation (Bullen et al, 2010), which are among the most highly reported side-effects of 
ENDS exposure.  
Flavored ENDS e-liquids.  Surveys show that sweet and fruit flavors are 
preferred by ENDS users over other options (Zare et al., 2018). A study by Welz et al. 
(2018) found that fruit flavored e-liquids showed higher toxicity than tobacco flavored e-
liquids (Welz et al., 2018). Sweeteners used in ENDS thermally degrade to toxic 
compounds including furans, 5-hydroxymethylfurfural (HMF) and furfural (FA) (Soussy 
et al., 2016; Jing & Lü, 2008; Fiore et al., 2012). These flavoring agents have been shown 
to cause irritation and inflammation to the human respiratory tract (Arts, Muijser, Appel, 
Frieke, Bessems, Woutersen, 2004; Farsalinos, et al., 2013). 
Flavoring agents have been found in “higher-than-safety” levels in a large portion 
of sweet-flavored e-liquids (Allen et al, 2015). Chronic inhalation of sweeteners may lead 
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to respiratory complications due to irritation and inflammation, with a potentially similar 
effect on the larynx. Finally, levels of furans and other toxic compounds have been 
shown to increase relative to increased heat and sweetener concentration (Soussy et al., 
2016).  
ENDS battery output voltage. Increased battery output voltage affects the yield 
and toxicity of ENDS aerosols (Breland, Soule, Lopez, Ramôa, El-Hellani, & 
Eissenberg., 2017). First generation devices produce voltage at an average of 3.7 Volts 
(V).  Second generation devices produce voltage at an average of 3-6V. Current 
generation devices can produce voltage of up to 8V. Studies on early or first generation 
devices showed that ENDS contain fewer toxic and carcinogenic compounds than 
conventional cigarettes (Goniewicz et al., 2014; Laugesen, 2008; Uchiyama, Inaba, & 
Kunugita, 2010); however, these studies were unable to take into account increases in 
ENDS power output ability beginning with later developed second generation devices.  
Kosmider et al. (2014) found that the amount of aerosol generated by a device is 
directly proportional to the power of the device battery. Many later generations of ENDS 
products are variable voltage, which allow users to increase battery output voltage, 
resulting in increased aerosol density in each inhalation (Rowell & Taran, 2015). 
Increasing battery output voltage leads to an increased temperature of the heating coil 
within ENDS. The user presses and holds an on/off switch, which sends a signal to the 
heating coil, theoretically allowing the user to raise the temperature of the atomizer up to 
662 degrees Fahrenheit (Balhas, Talih, Eissenberg, Salman, Karaoghlanian, Shihadeh, 
2014).  
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Increased battery output voltage has been shown to rapidly increase carbonyl 
levels within ENDS aerosol (Kosmider et al., 2014). Additionally, the increased battery 
output voltage results in more e-liquid consumed per puff, so users are not only exposed 
to increased levels of carbonyls but generally greater amounts of toxins due to increased 
density of the aerosol (Havel, Benowitz, Jacob & St.Helen, 2016; Kosmider et al., 2014; 
Floyd, Queimado, Wang, Regens & Johnson, 2018). Kosmider et al (2014) found that 
increasing voltage from 3.2 to 4.8V resulted in an increase of formaldehyde, 
acetaldehyde and acetone levels of up to and over 200 times what it was in ENDS aerosol 
produced at 3.2V.  Havel et al. (2016) found that levels of acetaldehyde, acrolein, and 
formaldehyde increased rapidly at voltages at or above 5V.  Kosmider et al. (2014) found 
that vapors from high voltage devices, with voltage at or above 4.9V, produce levels of 
formaldehyde that are in the range of levels reported in tobacco smoke. 
Reported health effects of ENDS. Most reported adverse effects of ENDS 
concern the mouth, throat, and respiratory systems (World Health Organization, 2015). In 
a 2012 study by Vardavas et al., researchers found that ENDS had an immediate adverse 
physiologic effect after short term use similar to effects caused by cigarette use and found 
that acute ENDS exposure may impair lung function (Vardavas, Anagnostopoulos, 
Kougias, Evangelolpoulou, Connolly & Behrakis, 2012). Lerner et al. (2015) found that 
ENDS aerosols were found to induce oxidative stress on human lung epithelial cells and 
trigger an inflammatory response (Lerner, Sundar, Yao, Gerloff, Ossip, McIntosh, 
Robinson, Rahman, 2015; Wu, Jiang, Minor, & Chu, 2014). A study on the effect of PG 
mist revealed dry throat and cough with both acute and chronic exposure (Varughese, 
Teschke, Brauer, Chow, van Netten, Kennedy, 2005). Additionally, e-liquids were found 
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to be cytotoxic to oropharyngeal tissue. The epithelium of the oropharynx is similar to the 
tissue within the larynx (Welz et al., 2018), which allows the possibility of a similar 
effect on laryngeal structures.  
Anatomy and Physiology of the Larynx 
The human vocal folds are located within the larynx, which is anatomically 
positioned at the top of the trachea at the levels of the cervical vertebrae 3 through 6 (C3 
– C6) in adults (Figure 1.5). Healthy vocal folds are required for airway protection, 
respiration, swallowing, and phonation or voicing. To produce phonation, the airstream 
passes between the two vocal folds that come together and vibrate due to both myoelastic 
and aerodynamic forces (Figure 1.6).  
 
Figure 1.5 Sagittal view of vocal folds within larynx positioned at level of C3-C6 
(From: Airway Management. (n.d.). Retrieved January 13, 2019, from LSU Health shreveport website: 
https://LSUHealthShreveport/departments/ClinicalDepartments/OralandMaxillofacial/omfsservesprovided/
airwaymanagment/OMFSAirway.aspx) 
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Figure 1.6 Vocal fold vibration caused by airstream from the lungs in anterior view 
(From Understanding Voice Production. (2013, August 31). Retrieved January 13, 2019, from THE VOICE 
FOUNDATION website: https://voicefoundation.org/health-science/voice-disorders/anatomy-physiology-
of-voice-production/understanding-voice-production/) 
 
True vocal fold anatomy. The vocal folds consist of 3 layers: the epithelium of 
the mucosa, the lamina propria, and the vocalis muscle, with blood vessels interwoven 
throughout. The lamina propria is further divided into three layers: superficial, 
intermediate and deep. The epithelium is composed of squamous stratified epithelium. 
The superficial lamina propria (SLLP), or Reinke’s space, is an underlying layer of loose 
connective tissue (Figure 1.7). The epithelium and Reinke’s space make up the mucosal 
cover, which can be observed moving during vocal fold vibration. The movement of the 
mucosal cover during vocal fold vibration is known as the mucosal wave. The cover 
gives the vocal folds their pearly-white appearance. The mucosal cover enfolds the vocal 
ligament and the vocalis muscle. The intermediate and deep layers of the lamina propria 
make up the vocal ligament.  The vocal ligament is the elastic component of the vocal 
folds. Reinke's space and the underlying vocal ligament together constitute the lamina 
propria. 
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Figure 1.7 Coronal cross-section of a vocal fold (left) and three-dimensional model of the layers (right). 
From Elsevier. Finck C, Lejeune L. Structure and oscillatory functions of the vocal fold. In: Stefan M. 
Brudzynski, ed. The Handbook of Mammalian Vocalization: An Integrative Neuroscience Approach. 
Chapter 10.2. Figure 2. Copyright Elsevier (2009) 
 
Changes in vocal fold tissue influence the function of the vocal folds for voice 
production. The epithelial surface of the vocal folds is covered by a thin layer of 
fluid/mucus, which influences the biomechanics of vocal fold vibration (Leydon, 
Sivansanker, Lodewyck, Atkins, & Fisher, 2009). This thin layer of fluid/mucus is 
continuous with the tongue, pharynx, and trachea and is covered with sensory receptors 
and mucus-secreting glands. Irritation or drying of this mucosa can lead to a hoarse vocal 
quality, or when severe, the epithelial cells within this lining can become malignant.  
Reinke's space also plays a major role in the vibration of the vocal folds (Hirano, 1980, 
1981). Movement of the epithelium and Reinke’s space form the mucosal wave. During 
vocal fold vibration, the mucosal wave periodically interrupts expiratory airflow, 
resulting in phonation. If the mucosal cover is stiff/resists movement or is overly pliable, 
this will alter the resulting tone produced by the wave.  The majority of vocal fold 
pathologies develop in Reinke’s space, and include polyps, nodules, and edema. The 
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accumulation of fluid/swelling in Reinke’s space due to irritation, such as smoking, is 
termed “Reinke’s Edema”.  
Laryngeal cartilages.  The larynx, or voice box, consists of nine cartilages, 
which are connected via ligaments and muscle (Figure 1.8). These include three unpaired 
and three paired cartilages. The large unpaired cartilages include the epiglottis, cricoid, 
and thyroid, which form the body of the larynx (Figure 1.9). The three paired cartilages 
include the corniculates, arytenoids, and cuneiforms. The cricoid, thyroid and the 
arytenoids have an important role in the phonatory function of the larynx. The small 
paired cartilages, corniculates and cuneiforms, have a minimal role in voicing, and the 
primary role of the epiglottis is airway protection.  
 
Figure 1.8 Laryngeal cartilages 
(From Team, H. J. (2017, October 5). Pharynx - Anatomy & Function in Respiratory System. Retrieved 
January 26, 2019, from Health Jade website: https://healthjade.com/what-is-the-pharynx/) 
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Figure 1.9 Aerial anterior view of epiglottis, cricoid and thyroid cartilages forming body of the larynx.  
(From: ELLO. (n.d.). Retrieved January 27, 2019, from https://zentrum.virtuos.uni-
osnabrueck.de/wikifarm/fields/english-
language/field.php/PhoneticsandPhonology/JourneyAlongTheVocalTractPage2) 
 
Laryngeal structures. Structures that are visible during endoscopic evaluation 
include structures within and above the laryngeal vestibule. Structures within the 
laryngeal vestibule include the aryepiglottic folds, ventricular (false) vocal folds, true 
vocal folds, the anterior and posterior commissures of the glottis, laryngeal ventricle, 
interarytenoid space, and trachea.  The structures located above the laryngeal vestibule 
include the epiglottis and other areas within the pharynx (throat).  
The aryepiglottic folds extend between the arytenoids and epiglottis. The 
ventricular vocal folds lie superior to the true vocal folds and inferior to the aryepiglottic 
folds.  The true vocal folds are located inferior to the ventricular folds and above the 
trachea at the glottis. The glottis includes the true vocal folds and the anterior and 
posterior commissures. The anterior commissure is the midline area of the glottis where 
the vocal folds meet anteriorly and where they are attached to the thyroid cartilage. The 
posterior commissure of the glottis lies anterior to the cricoid cartilage in between the 
arytenoid cartilages.  The laryngeal ventricle is the area between the ventricular and true 
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vocal folds on either side and extends nearly their entire length. The interarytenoid space 
is found between the arytenoid cartilages and posterior to the glottis. The trachea is 
located just below the vocal folds and is visualized during vocal fold abduction 
(opening).  
The epiglottis is located adjacent to the tongue base and anterior and superior to 
the laryngeal vestibule.  Some areas within the pharynx that may also be visualized 
during endoscopic evaluation include the tongue base and valleculae, which lie superior 
to the laryngeal vestibule. (Figure 1.10). 
 
Figure 1.10 Aerial posterior view of vocal folds  
(From: Anatomy of the glottis. (n.d.). Retrieved January 27, 2019, from 
http://www.aboutcancer.com/anatomy_glottis.gif) 
 
Stroboscopic Assessment 
      Stroboscopic imaging of the vibratory function and appearance of the vocal folds 
plays a central role in the assessment and treatment of vocal pathologies.  The 
effectiveness of laryngeal stroboscopy for investigation of the vibratory and nonvibratory 
function of the larynx is well proven (Bless, Hirano & Feder, 1987; Patel, Dailey & 
Bless, 2008). Videostroboscopy allows the clinician to record vocal fold patterns for 
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visual inspection of laryngeal structure and function. Stroboscopy is a term used to 
indicate a specific type of light used during visualization of the laryngeal area. Because it 
is impossible for the naked eye to see the rapidly vibrating vocal folds, in stroboscopy, 
brief flashes of light at a frequency just slightly less than the rate of vocal fold vibration 
slow the perceived rate of movement patterns of the vocal folds to allow for assessment 
(Faure & Muller, 1992).  
Vocal fold parameters viewed with stroboscopy.  Efforts to standardize 
perceptual assessment of the vocal folds using videostroboscopy have resulted in rating 
systems of vocal fold vibratory and nonvibratory parameters. The Voice-Vibratory 
Assessment with Laryngeal Imaging (VALI) is one such rating form developed by 
Poburka, Patel, and Bless (2016) (Figure 1.11). This assessment is used to create a more 
reliable visuoperceptual evaluation of the videostroboscopic examination. VALI is an 
updated version of the Stroboscopy Evaluation Rating Form (SERF) (Poburka, 1999; 
Poburka & Bless, 1998). The parameters assessed using VALI include the following: 
glottal closure, amplitude, mucosal wave, vertical level, nonvibrating portion, 
supraglottic activity, free edge contour, regularity, phase symmetry, and phase contour 
(Figures 1.12-1.21).  Additionally, nonvibratory observations, which include erythema 
(redness), edema (swelling), varices (vascularity), and mucus are rated according to a 
rating system adapted from Hirano and Bless (1993) (Figure 1.22). During examination, 
the clinician uses the following definitions and images of each parameter assessed 
according to descriptions and images provided in the VALI rating form (Poburka et al., 
2016).  
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Figure 1.11 VALI rating form for stroboscopy. Voice-Vibratory Assessment with Laryngeal Imaging 
(VALI) -- Stroboscopy (Poburka, B., Patel, R., and Bless, D. 2016). 
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Figure 1.11 (continued) 
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Glottal closure. Glottal closure is the appearance of the glottis during the most 
closed portion of the glottal cycle at normal pitch and loudness (Poburka et al., 2016). 
The glottis is a term that defines the vocal folds and the space between them within the 
larynx. Analysis of various closure patterns is helpful in diagnosing laryngeal pathology. 
Glottal closure patterns assessed using VALI include: complete, anterior gap, posterior 
gap, hourglass, spindle gap, irregular, and incomplete (Figure 1.12). Normal closure 
patterns include complete closure and posterior gap. Abnormal glottal closure patterns 
include anterior gap, hourglass closure, spindle gap, irregular closure, and incomplete 
closure.  
In the complete closure pattern, the vocal folds fully adduct without any glottic 
spaces or gaps. In the posterior gap pattern, there is a small glottic gap, which is 
triangular in appearance and located in the posterior aspects of the vocal folds. This 
closure appears to be common in Caucasian and African American females more so than 
males, but a study by Meeks (2017) suggested that posterior gap in African American and 
Asian males may not be pathologic as well.  
A small glottic gap exists anteriorly during vocal fold adduction in the anterior 
gap closure pattern. This pattern can be indicative of vocal fold pathology, including 
vocal nodules. In the hourglass pattern, the vocal fold closure occurs only at one point, 
and is typically observed in the medial to anterior one-third of the vocal folds. There is no 
adduction anterior or posterior to this point. The hourglass closure pattern is associated 
with the presence of bilateral vocal nodules located at the point of vocal fold closure.  
In the spindle gap closure pattern, the vocal folds adduct in both the anterior and 
posterior aspects but bow outward from midline in the medial aspects leaving a glottic 
 
 
21 
space. The spindle pattern is most commonly seen with hypofunctional dysphonia and 
presbyphonia. In the irregular closure pattern, the vocal folds do not adduct along their 
length and cannot complete closure during adduction due to irregular and rough margins. 
The irregular pattern can be indicative of vocal fold pathology, including laryngeal 
cancer. Incomplete closure is observed when the vocal fold margins are smooth in 
appearance and the vocal folds do not fully adduct along the entire length. Incomplete 
closure can indicate abnormality and hyperfunctional dysphonia.  
In instances where the vocal folds show more than one pattern, the closure pattern 
is termed “variable closure” (Poburka et al., 2016). Images for comparison are provided 
on the rating form (Figure 1.12). Closure patterns are documented at low frequencies and 
high frequencies for each participant.  
 
Figure 1.12 Glottal Closure patterns 
From VALI rating system (Poburka et al, 2016) 
 
 Amplitude. Poburka et al. (2016) define amplitude as the magnitude of lateral 
movement of the vocal folds. In normal conditions, the point of contact of the lateral 
movement of the vocal folds is one half the width of the visible portion of the vocal folds.  
Increased vocal intensity or loudness will increase amplitude. Increased stiffness, mass, 
and pitch will reduce amplitude. VALI uses a numerical rating system that rates 
movement from 2-10 and corresponding images aid in documentation of the point of 
contact of lateral movement (Figure 1.13). A rating of 2 is given with minimal lateral 
separation of the vocal folds when voicing at normal pitch and loudness, indicating 
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significantly reduced amplitude or intensity. A rating of 10 is maximal lateral separation 
of the vocal folds, indicating maximum amplitude or intensity. Amplitude is reported 
separately for the left and right vocal folds. 
 
Figure 1.13 Amplitude rating system 
From VALI rating system (Poburka et al, 2016) 
 
Mucosal wave. Mucosal wave is the magnitude of movement of the mucosal 
membrane (Poberka et al., 2016). During vocal fold vibration, the mucosal wave 
originates on the medial surface of the vocal folds and moves laterally across the superior 
surface of the mucosal cover, spreading bilaterally (Hirano & Bless, 1993). Any change 
in the mucosal cover will alter the mucosal wave (Hirano, 1981). The movement of the 
mucosal wave also provides information about the status of the tissue that is between the 
cover and the vocalis muscle of the vocal folds.   
If the vocal fold is stiff and resists movement or is edematous, this may reduce the 
mucosal wave or cause it to be absent. As said, most lesions affect the cover, causing 
restricted movement of the mucosal wave. Edema of the epithelium increases mass and 
stiffness of the cover, which interferes with the vibratory function of the vocal folds, thus 
also affecting the mucosal wave. Reinke’s Edema can make the vocal fold cover more 
massive, less stiff, and more compliant, resulting in an altered mucosal wave. 
 Using videostroboscopy, the location of altered mucosal movement can often be 
specifically noted. VALI uses a numerical rating system from 2-10 for movement of the 
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mucous membrane at normal pitch and loudness (Figure 1.14). A rating of 2 coincides 
with minimal motion of the mucosal wave, and would indicate increased swelling, 
stiffness, or otherwise restricted, nearly absent movement. A rating of 10 indicates 
movement of the mucosal wave across the total visible width of the vocal folds. A rating 
greater than 8 bilaterally indicates normal motion of the mucosal wave. Mucosal wave 
will be rated separately for the left and right vocal folds.  
 
Figure 1.14 Mucosal wave rating system 
From VALI rating system (Poburka et al, 2016)\ 
 
 
Vertical level. Poberka et al. (2016) define vertical level as whether the vocal 
folds meet on plane. If the vocal folds do not meet on plane, the form provides options 
for description of off plane meeting, i.e., whether the left or right vocal fold is lower 
(Figure 1.15). Structural abnormalities in one or more vocal folds can lead to 
approximation of vocal folds off the vertical plane (Van den Berg, 1968). 
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Figure 1.15 Vertical Level rating system 
From VALI rating system (Poburka et al, 2016) 
 
Non-vibrating portion. Non-vibrating portion is defined by Poberka et al. (2016) 
as adynamic segments of tissue that appears stiff. Stiff tissue is indicative of pathology, 
including nodules, polyps, edema, or early signs of laryngeal carcinoma, which originates 
in the mucosal cover. The gradual change in stiffness throughout the vocal fold structure 
is an important histological component of healthy vocal folds (Hirano & Bless, 1993). 
Stiffness gradually decreases from the stiff vocalis muscle to the pliable mucosal cover.  
Any change in the stiffness of the tissue alters how the structures function.  
The superficial layer of the vocal folds is where edema often develops (Hirano, 
1981). Edema and lesions increase mass and stiffness, which interferes with vocal fold 
vibration (Hirano, 1981). The VALI rating form shows vocal folds with 10 ovals on the 
surface of each fold. Each oval accounts for 10% of the true vocal fold.  The evaluator 
shades in the ovals on the rating form that correspond to the area of stiffness or reduced 
or absent movement observed during videostroboscopy (Figure 1.16).  
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Figure 1.16 Non-vibrating portion rating system 
From VALI rating system (Poburka et al, 2016) 
 
 Supraglottic activity. Poburka et al. (2016) define supraglottic activity as 
constriction of supraglottic structures during sustained phonation. Supraglottic structures 
are those that lie above the true vocal folds and below the tongue base. These include the 
ventricle, the ventricular folds, the epiglottis, the arytenoids, the laryngeal aspects of the 
aryepiglottic folds, and the vestibule (Stager, 2011). Supraglottic activity may occur due 
to vocal abuse or misuse, compensation of the larynx due to pathology, illness or injury, 
and/or the type of endoscope used in assessment (Stager, Bielamowicz, Regnell, Gupta, 
Barkmeier, 2000; Nospes, Kuhr, Napiontek & Keilmann, 2011). Two types of 
supraglottic constriction or compression may be noted: static or dynamic. Static activity 
initiates when phonation begins and remains until vocal fold vibration ceases. Dynamic 
activity changes throughout speaking tasks. A subset of dynamic activity is the 
occurrence of compression upon initiation of a speaking task (Stager, 2011).  
Normal arytenoid movement is symmetrical during adduction and abduction. 
Asymmetrical movement of the arytenoids as well as hyperfunction are noted by the 
clinician. During phonation, the ventricular folds should vibrate minimally and be 
relatively stationary and remain apart. Vocal hyperfunction refers to conditions of abuse 
and/or misuse of the vocal mechanism due to excessive and/or imbalanced muscular 
forces (Hillman, Holmberg, Perkell, Walsh & Vaughan, 1989). Anterior-posterior and 
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mediolateral ventricular fold compression are rated from 0-5 (Figure 1.17). A rating of 0 
indicating normal supraglottic activity and 5 indicating maximal abnormal supraglottic 
activity. 
 
Figure 1.17 Supraglottic activity rating system 
From VALI rating system (Poburka et al, 2016) 
 
Free edge contour. Poberka et al. (2016) define free edge contour as the 
smoothness and/or straightness of free edge of the vocal folds. Evaluators are instructed 
to rate right and left vocal folds individually during abduction.  Descriptions of free edge, 
which are accompanied by a corresponding image on the VALI rating form, include 
normal, convex, concave, irregular, and rough (Figure 1.18). Abnormal vocal fold edge 
may be due to histological alteration following chronic irritation or edema. Edematous 
vocal folds may have a convex appearance, whereas thinning vocal folds may have a 
concave appearance. Irritated vocal folds or those with lesions or other histological 
alterations may present with an irregular or rough appearance.  
  
Figure 1.18 Free Edge Contour rating system 
From VALI rating system (Poburka et al, 2016) 
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Phase closure. Phase closure is defined by Poberka et al. (2016) as the relative 
durations of appearance of consecutive glottal cycles. A glottal cycle consists of one open 
phase and one closed phase. In normal symmetrical phase patterns, the timing of the open 
phase and closed phase is almost equal. Symmetrical phase closure indicates that the 
folds have similar mechanical properties. When vocal quality is breathy or weak, as with 
hypoadduction or when lesions or bowing interfere with vocal fold closure, the open 
phase predominates. When vocal quality is harsh or strangled as with hyperadduction, the 
closed phase predominates. 
 VALI provides a continuum for rating phase closure. The clinician marks the 
point on the continuum where phase closure resides. The continuum includes three 
descriptions: phase closure when open phase predominates, phase closure when the 
phases are nearly equal, and phase closure when closed phase predominates. For phase 
closure that falls between two descriptions, the clinician identifies the appropriate point 
on the continuum, e.g., between nearly equal phase closure and when closed phase 
predominates. Phase closure is rated at the point of contact of the vocal folds (Figure 
1.19). 
 
Figure 1.19 Phase Closure rating system 
From VALI rating system (Poburka et al, 2016) 
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Phase Symmetry. Phase symmetry is defined as the degree to which the vocal 
folds move as mirror-opposite images of each other, or 180° phase difference (Poburka et 
al., 2016). In normal symmetrical phase patterns, the bilateral vocal fold movement is 
almost equal. Symmetry in phase indicates that the vocal folds have similar mechanical 
properties. The evaluator selects the percentage of exam time where the vibration is 
symmetrical. The form provides a visual description of asymmetry and symmetry (Figure 
1.20). Phase asymmetry is indicative of unilateral changes in vocal fold tissue, e.g., 
lesions and edema.  
 
Figure 1.20 Phase Symmetry rating system 
From VALI rating system (Poburka et al, 2016) 
 
Regularity. Regularity is defined as the consistency of cycles or the type of phase 
closure observed (Poburka et al., 2016). The evaluator indicates the percentage of the 
exam that vibration is regular, from always regular to never regular. Lack of regularity in 
phase closure is indicative of vocal pathology, such as the presence of lesions or swollen 
tissue. This portion of the rating form includes images depicting regularity and 
irregularity (Figure 1.21).  
 
Figure 1.21 Regularity rating system 
From VALI rating system (Poburka et al, 2016) 
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Nonvibratory observations. Poburka et al. defined nonvibratory observations as 
the structural observations not mentioned elsewhere. These include structural differences, 
such as asymmetry, erythema, vascularity, and mucus. Erythema refers to redness of the 
vocal folds and laryngeal structures. The presence of erythema is indicative of irritation, 
dehydration, and/or trauma of the tissue.  Observations may involve the interarytenoid 
space, arytenoids, aryepiglottic folds, ventricular folds, ventricle, and epiglottis. 
Subjective evaluation of nonvibratory observations is rated from “within normal limits” 
or “none” to “severe” (Hirano & Bless, 1993) (Figure 1.23). 
Parameters VF Rating 
Vocal fold (VF) 
varices  
right 0 = wnl 1 = mild  2 = moderate  3 = severe  
left 0 = wnl 1 = mild  2 = moderate 3 = severe 
VF edema right 0 = no edema 1 = mild  2 = moderate 3 = severe 
left 0 = no edema 1 = mild  2 = moderate 3 = severe 
VF 
discoloration 
right 0 = pearl white 
appearance 
1 = mild  2 = moderate 3 = profound  
left 0 = pearl white 
appearance 
1 = mild  2 = moderate 3 = profound  
VF mucus right 0 = wnl 1 = mildly 
thick/thin and 
clear 
2 = moderately 
thick/thin and 
mildly opaque 
3 = severely 
thick/thin and  
moderately 
opaque 
left 0 = wnl 1 = mild  2 = moderate 3 = severe 
Ventricular fold 
erythema 
right 0 = wnl 1 = mild  2 = moderate 3 = severe 
left 0 = wnl 1 = mild  2 = moderate 3 = severe 
Arytenoid 
Erythema 
right 0 = wnl 1 = mild  2 = moderate 3 = severe 
left 0 = wnl 1 = mild  2 = moderate 3 = severe 
Arytenoid 
edema 
right 0 = wnl 1 = mild  2 = moderate 3 = severe 
left 0 = wnl 1 = mild  2 = moderate 3 = severe 
*wnl = within normal limits 
Figure 1.22 Nonvibratory observations rating form (adapted from Hirano & Bless, 1993). 
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Acoustic Analysis 
      Acoustic parameters provide objective and noninvasive measures of the function 
of laryngeal anatomy. These measures are successful at monitoring changes in voice 
quality over time. Among the vocal parameters assessed are Fundamental Frequency (F0) 
and perturbation measures, including jitter and shimmer. Acoustic analysis software 
allows the clinician to record vocal productions for perceptual analysis and provides 
graphic imaging and statistical analysis of acoustic measurements.  
F0 provides information on the mass and stiffness of the vocal folds. F0 is the 
acoustic correlate of pitch, or the perceived rate of vocal fold vibration. As F0 changes, 
the listener perceives a change in pitch. F0 refers to the frequency that occurs most often 
during phonation. It is the number of vocal fold phases (openings and closings) that occur 
in one second, as measured in Hertz (Hz) or cycles per second.  A typical adult male will 
have a F0 between 85 and 155 Hertz, while an adult female will have a F0 between 165 to 
255 Hertz. The norm for females ages 18-39 is 214.39 (SD 26.76), and the norm for 
males ages 18-39 is 106.41 (SD 13.29) (Shaefer et al., 2008). F0 is determined by length, 
tension, and mass of the vocal folds (Boone et al., 2011).  
Vocal perturbation measures include jitter and shimmer. Vocal perturbation refers 
to small changes in the vocal system.  Perturbation measures provide strong measures of 
the basic perceptual elements of voice quality (Wolfe, Finch & Martin, 1997). Jitter refers 
to the abnormalities or variation in cycle-to-cycle signal frequency, which relates to pitch. 
The norm for males ages 18-39 for jitter is 1.41% (SD 0.32%) (Shaefer et al., 2008). The 
norm for females ages 18-39 for jitter is 0.82% (SD 0.28%) (Shaefer et al., 2008).  
Shimmer refers to the abnormalities in the amplitude of vocal fold vibration, which 
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relates to intensity or loudness. The norm for males for shimmer is 2.14% (SD 0.32%) 
and the norm for females for shimmer is 1.59% (SD 0.68%) (Shaefer et al., 2008).  
Raised jitter and/or shimmer values may be indicative of changes that have occurred in 
the structure of the laryngeal epithelium and is a probable indicator for a physiological 
disorder (Wolfe, Cornell & Palmer, 1991; Hirano & Bless, 1993; Lourenco, Costa, & 
Filho, 2014).  
Literature Review 
A limited number of studies citing the long-term health effects of ENDS are 
available. This is likely due to the recent availability of ENDS products on the global 
market as well as a lack of regulations and standards governing ENDS production. 
Reports of adverse effects have included complaints of throat symptoms, including 
irritation of the throat during ENDS inhalation (Polosa et al., 2014). Additionally, similar 
types and levels of toxins to those in cigarette smoke have been found in ENDS aerosols. 
Despite evidence that ENDS may have an effect on the laryngeal structures, to the best of 
this clinician’s knowledge, to date, no human studies and only one animal study on the 
effect of ENDS on the larynx has been published.  
A study conducted by Salturk et al. (2015) assessed the effects of ENDS on the 
laryngeal mucosa of rats, with an additional focus on comparing effects of convection 
heat of ENDS aerosol to combustion heat produced by cigarette smoke on the larynx. 
This study assessed the histopathologic effects of ENDS on the vocal fold mucosa of 16 
rats after exposure for 60 minutes per day for four weeks to ENDS with 0.9% (wt/vol) or 
9 mg/ml nicotine. Rats were exposed to ENDS aerosol within a smoke drum, which 
contained two holes: one for inspiration and one for expiration. With the ENDS device 
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placed in the inspiration hole, 200 mL/minute of aerosol entered the drum and was fully 
distributed within 20 minutes. At the end of four weeks, the rats were sacrificed, and each 
vocal fold was removed and examined histologically. Salturk et al (2015) found that 
ENDS may have effects on the vocal fold epithelium.  The study found that epithelial 
responses, which included hyperplasia (increase in cell number) and metaplasia (change 
in cell type), were evident though not found to be significant.  
Some gaps in this study by Salturk et al (2015) include the fact that exposure was 
a controlled application, which does not mirror use in humans. Humans typically use 
ENDS in approximately 5-minute intervals or sessions, consistent with cigarette use, 
and/or take single puffs frequently, potentially 100s of times, throughout the day. ENDS 
users puff deeply and directly from a device, hold the material briefly in the lungs and 
then exhale, rather than inhaling aerosol that is distributed through the air during patterns 
of normal respiration. The nicotine solution used in this study was 0.9% wt/vol. or (9 
mg/ml), which is not representative of the wide range of nicotine levels that are currently 
consumed by human beings, e.g., Juul, which has 59 mg/ml.  Additionally, the study did 
not list the battery voltage or e-liquid contents used to create the aerosol, which have 
been shown to alter the toxicity of ENDS aerosol (Kosmider et al., 2014; Rowell & 
Taran, 2015).  Finally, this study was limited to four weeks duration and was also limited 
in the number of participants included.  
While studies on the effects of ENDS on the larynx are limited to one, the effect 
of cigarette smoke is well studied. Reported histologic changes in the larynx in relation to 
smoking include atypical microscopic changes in the true vocal fold, false vocal folds, 
and the area above and below the level of the vocal folds, including epithelial hyperplasia 
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and metaplasia (Auerbach et al., 1970; Levendoski, Leydon, & Thibeault, 2014; Gaafar 
& Al-Monsour, 1981). Smoking has been found to cause Reinke’s edema, chronic 
laryngitis, and diffuse vocal fold polyps as well as triggering reflux that affects the 
larynx, termed laryngopharyngeal reflux (Öğüt & Kiliç, 2013; Stanciu & Bennett, 1972). 
Smoking leads to chronic irritation and can lead to an increase in vocal fold mass and 
thickening of vocal fold epithelium, as well as carcinomas in the epithelium (Kelleher, et 
al., 2014). Auerbach et al. (1970) found that effects of cigarette smoke on laryngeal 
epithelium were similar to previous findings of histologic change on bronchial 
epithelium. Similarly, studies have shown negative effects of ENDS on bronchial 
epithelium (Lerner et al., 2015), which further studies may find to be similar in laryngeal 
epithelium of ENDS users. Additionally, studies on the toxicity of ENDS reveal similar 
toxins to those found in cigarette smoke and, with sufficient battery output, ENDS 
aerosol has been shown to contain toxins at similar levels as well. 
A study by Awan and Morrow (2007) compared the laryngeal characteristics of 
young adult female smokers versus nonsmokers using videostroboscopy.  The goal of this 
study was to observe any early effects of smoking on the laryngeal structures and 
phonatory function. Participants included 34 nonsmoking females and 30 smoking 
females between the ages of 18 and 30 years old. Nonsmokers were operationally defined 
as participants who did not smoke and had not smoked for at least 5 years before the time 
of the study. Smokers were operationally defined as individuals who had smoked at least 
two cigarettes per day for at least one year. This study found a significant relationship 
between smoking and edema, erythema, and discoloration of laryngeal structures. It also 
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found a significant relationship between abnormal phase symmetry and increased glottal 
gap size during the closed phase of phonation (Awan & Morrow, 2007).  
A study conducted by Banjara, Mungutwar, Singh, and Gupta (2011) compared 
the larynges of smokers with that of non-smokers using videostroboscopy and acoustic 
voice analysis to determine the effects of smoking on the laryngeal anatomy and vocal 
physiology of smokers. The study’s findings supported prior research that shows cigarette 
smoke has a significant impact on the larynx (Myerson, 1964; Auerbach, Hammond, & 
Garfinkel, 1970; Awan & Morrow; 2007; Banjara et al., 2011; Kelleher et al., 2014; Öğüt 
& Kiliç, 2013; Stanciu & Bennett, 1972). 
A sampling of 50 male smokers and 50 male nonsmokers between the ages of 18 
and 60 years participated in the study. Smokers were defined as any participant who, at 
the time of the study, had smoked at least two cigarettes per day for at least one year. 
Nonsmokers were defined as those who, at the time of the study, did not smoke and who 
had not smoked for five years before the study.   
The researchers rated various aspects of the vocal folds as visualized on 
videostroboscopy using a rating system described by Hirano and Bless (1993). A 
criterion level of at least two judge agreements was required for a particular rating to be 
documented. Additionally, acoustic voice analysis and EGG measures were completed 
using Electroglottography. Acoustic analysis included the following parameters: 
fundamental frequency, frequency perturbation (shimmer), amplitude perturbation (jitter), 
F0 tremor, normalized noise energy (NNE), harmonic-noise ratio (HNR), signal-noise 
ratio (SNR), amplitude tremor, maximum phonation time (MPT), and S/Z ratio. The 
following EGG parameters were evaluated: fundamental frequency, EGG-Jitter, EGG-
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Shimmer, EGG F0 tremor, contact quotient (CQ), contact index (CI), CQ perturbation, CI 
perturbation, opening rate and closing rate.  
Banjara et al (2011) found a significant relationship between smoking and 
abnormal vocal fold edge, abnormal texture, edema, erythema, abnormal mucosal cover, 
abnormal phase symmetry and abnormal pliability/stiffness.  Abnormal vocal fold edge in 
smokers included primarily swollen and rough vocal edge. These researchers found that 
the most common texture differences between smokers and non-smokers were mild to 
moderate roughness in smokers. This study also observed a highly significant relationship 
between the presence of edema and smoking as well as a significant relationship between 
increased erythema and smoking.  
Banjara et al. (2011) observed a significant difference in abnormal mucosal cover 
in smokers as compared to nonsmokers. The most common mucosal cover abnormality 
observed in smokers was thick mucosal cover, which the study suggested was likely a 
result of the vocal folds chronic inflammatory response to cigarette smoke.  
Banjara et al. (2011) observed a significant difference in abnormal phase 
symmetry in smokers as compared with nonsmokers. The most common abnormal phase 
symmetry observed in conventional smokers was asymmetrical phase symmetry (Banjara 
et al., 2011). Banjara et al. (2011) observed a significant relationship between changes in 
stiffness/pliability and smoking. Specifically, the study found mild to moderate stiffness 
in smokers. Researchers suggested this increase in stiffness was likely the result of long-
standing edema caused by smoking. The study suggested that studies with younger 
participants may not see a significant relationship between smoking and stiffness due to 
long-standing edema occurring only after long term use.  
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The most common glottal closure patterns observed in the study were spindle gap 
and irregular glottal closure patterns; however, no significant difference was observed 
between abnormal glottal closure pattern findings.  
Results of acoustic analysis in this study showed decreased values of F0, 
significantly higher values of perturbation measures (jitter and shimmer), and 
significantly increased F0 tremor (Banjara et al., 2011). These findings are consistent with 
other studies on the acoustic measures of cigarette smokers (Damborenea et al., 1999). 
The study also found raised values of NNE in smokers as compared to non-smokers, as 
well as lower values of SNR, and lower values of MPT. Finally, raised values of s/z ratio 
were discovered in smokers as compared to non-smokers in this study. 
An important gap in this study by Banjara et al. (2011) as well as the study by 
Awan and Morrow (2007) is that while these studies provide a detailed analysis of 
cigarette smokers as compared to non-smokers, they do not compare smokers and non-
smokers with ENDS users. ENDS use is rapidly increasing. ENDS are used by former 
smokers for tobacco cessation and by nonsmokers as the initial form of nicotine use 
(Kaisar et al., 2016). As ENDS are commonly used by both smokers and nonsmokers, 
comparing the laryngeal anatomy and physiology of ENDS users to smokers and 
nonsmokers is necessary and has the potential to provide valuable insight into the effects 
of ENDS on the larynx. 
The purpose of the present study is to investigate the visual appearance and 
acoustic measures of the vocal folds and laryngeal structures of ENDS users as compared 
to smokers and nonsmokers. Because ENDS aerosol is inhaled in a similar manner and 
may contain similar types and levels of toxins as are present in cigarette smoke, it is 
 
 
37 
likely that ENDS may have a similar effect on laryngeal anatomy and physiology.  First, 
this study aims to discover whether acoustic analysis will reveal similarities in acoustic 
measures of ENDS users and smokers. It is hypothesized that ENDS users and smokers 
will experience a similar reduction in F0 and a similar increase in perturbation measures. 
Second, this investigation aims to determine whether there are similarities in the mucosal 
wave and vibratory characteristics of ENDS users as compared to smokers. It is 
hypothesized that ENDS users and smokers will present with similarities in vibratory 
characteristics, including mucosal wave movement.  Third, this study aims to investigate 
whether there are similarities in the visual appearance of the vocal folds of ENDS users 
as compared to smokers. It is hypothesized that the vocal folds of ENDS users will have a 
similar visual appearance to that of smokers.  Finally, this investigation aims to discover 
whether similarities exist in the visual appearance of laryngeal structures of ENDS users 
and smokers. It is hypothesized that the laryngeal structures of ENDS users will have a 
similar visual appearance to that of smokers.  
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CHAPTER II 
METHODS 
 
The investigation, materials, and procedures for this study were approved by the 
Institutional Review Board (IRB) of Cleveland State University. This investigator 
recruited, screened, and collected data for all participants. All data were collected in the 
voice lab of the Cleveland State University Speech and Hearing Clinic. Informed consent 
was obtained from each participant after receiving a detailed explanation of the nature of 
the study (Appendix A). 
A total of 20 healthy individuals participated in this study. Participants included 7 
ENDS users and 4 cigarette smokers. A control group of 6 non-smokers was also 
included in this study. Participants’ ages ranged from 18 to 35 years old, with an average 
of 28.14 (SD 7.10) years for ENDS users, an average of 30 (SD 2.45) years for smokers, 
and an average of 27.88 (SD 5.12) years for non-smokers.  As far as possible, participants 
in each group were matched closely for age and gender. Table I lists the participants’ 
characteristics in terms of age, gender, and grouping.  Participants were recruited via 
word of mouth and flyers through the student investigator. The student investigator 
provided monetary compensation to those willing to participate and to those who helped 
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to locate participants. Participation in this study included one sixty-minute session 
at Cleveland State University’s voice lab located at the Center for Innovation in Medical 
Professions (CIMP). The entire period of data collection combined for all participants 
was approximately three months. 
     To meet the inclusionary criteria, participants had to be between 18 and 35 years old. 
Race was not a factor. Gender was only a factor in the investigator’s attempts to match 
participants of a particular gender between groups. Based on their own personal account, 
participants were screened for conditions and daily habits known to cause visible changes 
in laryngeal anatomy and physiology, as well as changes in pitch and perturbation 
measures. All participants completed a questionnaire prior to data collection for the 
purpose of screening these areas (Appendix B). ENDS users and cigarette smokers were 
asked to use their devices or smoke within 15 minutes prior to data collection to 
minimize the variable of time since last use. All tasks were completed within the same 
visit using identical instructions (Appendix C and D), physical positioning, endoscope, 
and equipment.  
For the purposes of this study, ENDS users were defined as individuals with daily 
ENDS use for at least one year and no cigarette use for at least 5 years prior to data 
collection. Smokers were defined as individuals with daily cigarette use of at least two 
cigarettes per day for at least one year with no prior ENDS use by the time of data 
collection. Nonsmokers were defined as individuals with no cigarette use for at least 5 
years prior to data collection, and no history of ENDS use.  Exclusionary criteria 
included: any diagnosis of a vocal fold pathology or GERD at the time of data collection, 
respiratory/sinus infections affecting laryngeal health within two weeks of data 
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collection, a history of chronic overuse/abuse of the voice, and/or an overactive gag 
reflex.  
 
Group 
Gender Mean Age  
Female  Male  Age (years) SD 
ENDS 2 5 28.14 7.10 
Smokers 2 2 30.00 2.45 
Nonsmokers 4 2 27.88 5.12 
Table I: Gender and mean age by group 
Acoustic Analysis 
Acoustic analysis provides information on the function of the laryngeal anatomy 
and an objective measure of the vibratory characteristics and patterns of the vocal folds 
and laryngeal structures (Hirano & Bless, 1993). Abnormal acoustic measurements are 
indicative of vocal fold pathologies. The voice parameters assessed in acoustic analysis 
included F0, and vocal perturbation measures, including jitter and shimmer.  
Quantitative measures were collected on each participant using the Kaypentax 
Visi-pitch IV. This is a clinical instrumentation tool used by speech-language pathologists 
for assessment, treatment, and research purposes. It provides auditory and visual 
feedback as well as objective data for measuring fundamental frequency, perturbation 
measures and other acoustic information. Abnormalities within these measures reflect 
dysphonia or dysfunction, and may be indicative of vocal pathologies (Lourenco, Costa, 
& Filho, 2014).  The microphone was placed two inches from the participants’ mouth 
while the participant sustained the vowel /a/ in a natural voice for at least five seconds 
according to given instructions (Appendix C).  
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Videostroboscopy 
Videostroboscopy is used frequently by speech-language pathologists and 
otolaryngologists in assessment and treatment of vocal fold and laryngeal pathologies. 
KayPentax 70-degree Rigid StrobolaryngoscopeTM model 9106 was used to complete a 
videostroboscopic assessment of the vocal folds of each participant.  Topical anesthesia 
was not used for any of the participants. In this study, videostroboscopy was used to 
visualize and describe the laryngeal area of participating individuals. 
The endoscope used in this study is a standard strobolaryngoscope, with mounted 
camera and microphone attachment. The tip of the scope contains a fiberoptic strobe light 
for observation of the mucosal wave. A rigid endoscope was placed just beyond the 
tongue base while the participant vocalized according to given instruction (Appendix D). 
Vocal patterns were recorded and saved on an audiovisual recording on the KayPentax 
equipment for further review of laryngeal structures and function. This investigator 
directly observed and reviewed participant’s laryngeal structures and function according 
to the VALI rating form (Poberka et al., 2016). A criterion level of two judge agreements 
was required for a particular rating to be documented. The principal-investigator and 
student-investigator served as judges for this study.  The principal-investigator is a 
licensed speech-language pathologist and the student-investigator is a second-year 
graduate student in speech-language pathology. 
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Questionnaire 
 Each participant completed a questionnaire prior to administration of instrumental 
evaluations (Appendix B). The questionnaire included screening questions used to assess 
whether participants met inclusionary criteria to be part of this study. The questionnaire 
also included questions regarding vocal habits and any known vocal pathologies. In 
addition, participants answered questions detailing ENDS or cigarette use. ENDS users 
provided information regarding device used, length of use, flavors of e-liquid, frequency 
of use, and factors that contributed to initial/current ENDS use. Each questionnaire is 
identical for all participants, regardless of use or lack of use of ENDS or cigarettes.  
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CHAPTER III 
RESULTS 
 
This study investigated the appearance and function of the vocal folds and 
laryngeal structures of ENDS users as compared to smokers and nonsmokers using 
videostroboscopic and acoustic analysis. Acoustic analysis included 3 sets of variables: 
fundamental frequency, jitter percent, and shimmer percent. The results of acoustic data 
were assessed using SPSS Statistics 24 (IBM, Armonk, NY). Data collected were rated in 
comparison between groups, as well as to established norms for age and gender (Schaefer 
et al., 2008).  
The results of videostroboscopic data were analyzed in a descriptive manner 
according to the VALI rating form (Poberka et al., 2016). Information gathered was then 
coded numerically in order to obtain data for comparison as described by Poburka et al. 
(2016). For example, for free edge contour, a rating of “normal” was coded as 1, 
“convex” was coded as 2, and so on, without these numbers otherwise containing any 
descriptive value.  Additional observations noted on the VALI form, including 
discoloration, edema, erythema, and vascularity were rated from “within normal limits” 
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to severe using a code described by Hirano and Bless (1993). For example, no 
abnormal presence of vocal fold edema was rated 0, mild edema was rated 1, moderate 
edema was rated 2, and severe edema was rated 3. Information gathered from acoustic 
analysis and videostroboscopy was assessed using SPSS Statistics 24 (IBM, Armonk, 
NY). Videostroboscopic findings were then compared to acoustic data. The results of the 
self-assessment of ENDS users were used to assess whether any correlations could be 
made between self-assessment responses and findings from endoscopic and/or acoustic 
evaluation.  
Acoustic Results 
 A one-way between subjects analysis of variance (ANOVA) was conducted to 
compare the effect of the nicotine device used, including ENDS, cigarettes, or non-use, 
on three acoustic measures: fundamental frequency, shimmer percent, and jitter percent. 
Fundamental frequency was assessed separately for male and female participants across 
the three groups (Tables II and III).  Shimmer percent obtained from participants of both 
genders was compared across groups (Table IV). Jitter percent obtained from participants 
of both genders was also compared across groups (Table V). Finally, the number and 
percentage of ENDS users and smokers with normal and abnormal acoustic measures was 
presented in a table for comparison across groups (Table VI). All acoustic measures were 
collected at normal loudness and comfort level via Visi-pitch IV. The results are as 
follows: 
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Table II: Fundamental frequency measures using ANOVA among female ENDS users, smokers and non-
smokers. 
 
 
 
 
Table III: Fundamental frequency measures using ANOVA among male ENDS users, smokers and non-
smokers. 
 
 
 
 
Table IV: Shimmer Percent measures using ANOVA among all ENDS users, smokers and non-smokers. 
 
 
 
 
Table V: Jitter Percent measures using ANOVA among all ENDS users, smokers and non-smokers. 
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Table VI: Number and percentage of acoustic parameters rated as “normal” or “abnormal” compared to 
norms for age and gender for ENDS and smoker groups.  
Rated 
Characteristic 
ENDS 
 
Smokers 
Normal Abnormal Normal Abnormal 
Fundamental 
Frequency 
7 (100%) 0 (0%) 3 (75%) 1 (25%) 
Jitter Percent 5 (71%) 2 (29%) 2 (50%) 2 (50%) 
Shimmer 
Percent 
2 (29%) 5 (71%) 0 (0%) 4 (100%) 
Comparison with norms for males and female nonsmokers, ages 18-39 years (Schaefer et al., 2008). 
*Normal = within one SD of the mean; Abnormal = outside of one SD of the mean.  
 
No significant difference was observed between groups for any of the 
aforementioned acoustic parameters (significant at P < 0.05; marginally significant at P < 
0.09) using ANOVA. Marginal significance is commonly used to describe data obtained 
from a small sample size. This indicates a pattern to be explored in future research. When 
compared to norms for nonsmokers of similar age and same gender, fundamental 
frequency and jitter percent values for ENDS users and smokers in the present study were 
comparable to norms (Schaefer et al., 2008); however, comparison revealed abnormal 
shimmer percent in a majority of ENDS users as well as smokers when compared to 
norms for nonsmokers (Appendix E).  
Videostroboscopy Results 
 A one-way between subjects ANOVA was performed on data obtained using the 
VALI rating form and numerical coding of responses.  The following areas were rated 
using VALI: glottal closure, amplitude, mucosal wave, vertical level, non-vibrating 
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portion, supraglottic activity, free edge contour, phase closure, phase symmetry, and 
regularity. Non-vibrating portion was difficult to assess due to increased supraglottic 
activity in many participants. It was therefore removed from the list of parameters 
assessed in this study. Nonvibratory characteristics, which are a parameter assessed on 
VALI and distinct from non-vibrating portion, were noted on the VALI form during and 
after completion of videostroboscopy upon review of recorded video. Information 
gathered for each participant was then coded numerically for assessment using a one-way 
between subjects ANOVA.  
 ANOVA determined significant interactions between means of data collected 
using the VALI rating form (Table VII) and between means of data collected from 
descriptions of nonvibratory characteristics (Table IX). A Tukey Post Hoc test was then 
used to determine which relationships between the three groups were significant in the 
aforementioned areas (Tables VIII and X). 
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Table VII: ANOVA comparison of videostroboscopic parameters among ENDS users, smokers, and non-
smokers assessed using VALI rating form (Poberka et al., 2016).  
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Table VIII: Tukey multiple comparison of videostroboscopic parameters with significant relationships on 
ANOVA among ENDS users, smokers, and non-smokers assessed using VALI rating form (Poberka et al., 
2016).  
Abnormal mucosal wave, free edge, and phase closure show significant 
relationships in ENDS users as compared to nonsmokers (significant at P < 0.05).  
Reduction in mucosal wave was consistently noted to occur in the presence of increased 
edema and observed thick mucosal cover (Figure 3.1). Abnormalities in free edge were 
most commonly convex or irregular (Figure 3.2). Close phase predominating was the 
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most frequently occurring form of abnormal phase closure noted in ENDS users and was 
also consistently noted with the observed presence of edema. Abnormal phase symmetry 
and regularity show a marginally significant relationship in ENDS users as compared to 
nonsmokers (marginally significant at P < 0.09) (Figure 3.3), and again consistently 
noted with the observed presence of edema.  
    
Figure 3.1: Increased edema and thick mucosal cover of ENDS users resulting in a reduction in mucosal 
wave (left and middle); vocal folds of nonsmoker with normal mucosal wave (right). 
 
 
     
Figure 3.2: Irregular (left), convex (middle) abnormalities in free edge contour of ENDS users; normal free 
edge contour of nonsmoker (right) 
 
 
 
Figure 3.3: Abnormal phase symmetry in ENDS user 
 
Abnormal phase closure also shows a significant relationship in smokers as 
compared to nonsmokers. Abnormal mucosal wave and phase symmetry shows a 
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marginally significant relationship in smokers as compared to nonsmokers. Abnormal 
free edge was evident though not significant in smokers. No significant relationship was 
observed for glottal closure, amplitude, supraglottic activity, and vertical level; however, 
a pattern of abnormal supraglottic activity was evident in ENDS users as well as smokers 
(see Figure 3.4). 
 
 
Figure 3.4: Abnormal supraglottic activity (top row) in ENDS users (left and middle) and smoker (right) 
and normal supraglottic activity (bottom row) in nonsmokers (left and middle) and ENDS user (right).  
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Table IX: ANOVA comparison of nonvibratory observations among ENDS users, smokers, and non-
smokers subjectively assessed according to a rating system adapted from Hirano and Bless (1993) (see 
Figure 1.22) 
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Table X: Tukey multiple comparison of nonvibratory observations with significant relationships on 
ANOVA among ENDS users, smokers, and non-smokers subjectively assessed according to a rating system 
adapted from Hirano and Bless (1993) (see Figure 1.22). 
 
ANOVA revealed significant relationships between groups and abnormal vocal 
fold varices, vocal fold edema, vocal fold discoloration, and ventricular fold erythema 
(Table IX). A Post-Hoc Tukey analysis revealed which relationships were significant 
(Table X): Abnormal varices is characterized by capillary dilation or leakage. Abnormal 
varices showed a significant relationship in both smokers and ENDS users when 
compared to the nonsmoker group (Figure 3.5). Abnormal vocal fold edema is 
characterized by unilateral or bilateral inflammation in the superficial layer of the vocal 
folds, including Reinke’s space (see Figure 1.7). Abnormal vocal fold edema showed a 
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highly significant relationship in ENDS users as compared to nonsmokers (highly 
significant at P < .001). Abnormal vocal fold edema showed a significant relationship in 
smokers as compared to nonsmokers (Figure 3.6).  
                                                                 
Figure 3.5: Vocal fold vascularity in smoker (left) and no vocal fold vascularity in nonsmoker (right) 
 
                                                                              
Figure 3.6: Unilateral edema of reinke’s space in ENDS user vibrating upon inhalation (left); no abnormal 
edema in nonsmoker (right) 
 
 
Vocal fold discoloration is noted when vocal folds have a yellow or pink 
appearance, rather than the pearl-white appearance characteristic of healthy vocal folds. 
A significant relationship was noted between vocal fold discoloration and cigarette use 
when compared to the nonsmoker group, while a relationship was evident though not 
significant between vocal fold discoloration and ENDS use (Figure 3.7).  
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Ventricular fold erythema is characterized by reddening of the tissue due to 
irritation.  A marginally significant relationship was found between abnormal ventricular 
fold erythema and smokers when compared to nonsmokers (Figure 3.8); however no 
significant relationship was found between abnormal ventricular fold erythema and 
ENDS use. Additionally, no significant relationship was observed for abnormal arytenoid 
erythema, arytenoid edema, and vocal fold mucus between both ENDS users and smokers 
as compared to nonsmokers; however, a pattern of thick, white mucus was observed on 
the vocal folds of three of seven ENDS users, which was not observed on the vocal folds 
of smokers and nonsmokers (Figure 3.9).   
 
Figure 3.7: Yellowed appearance of vocal folds of ENDS user (left), reddened appearance of vocal folds of 
smoker (middle), and pearl white appearance of vocal folds of nonsmoker (right). 
 
                                                                  
Figure 3.8: Severe ventricular fold erythema in smoker (left); moderate to severe ventricular fold erythema 
in ENDS user (middle); and no abnormal erythema in nonsmoker (right) 
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Figure 3.9: thick, white mucus of ENDS user (left); thin, clear mucus of nonsmoker (right) 
 
Questionnaire Results 
All responses provided by ENDS participants on a general questionnaire were 
recorded and entered into a table for comparison (Table XI). Participants reported their 
age, device used, duration of use in years, flavors used, frequency of use (in times per 
day), and contributing factors in their decision to begin and continue using ENDS.  
According to ENDS user responses provided on the general questionnaire, 
participants used ENDS for an average duration of 3.64 (SD 2.06) years.  Those who 
reported using ENDS because they are trendy had used ENDS for three years or less. 
Five of seven participants report using ENDS because they believe it is a safer nicotine 
alternative to smoking cigarettes. Of seven total ENDS users, three reported using sweet 
flavored e-liquids, three reported using menthol or mint flavored e-liquids, and one 
reported using tobacco flavored e-liquids. Five of seven ENDS users report using 3rd or 
current generation devices. Finally, five of seven ENDS users report using ENDS greater 
than 20 times (sessions) throughout the day. 
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Table XI: ENDS users’ individual questionnaire responses  
Age 
(years) 
Device* length of 
use 
(years) 
Flavor Frequency**  Factors 
32 1,2 5 sweet >20x/day safer 
 
31 3 6 tobacco >20x/day safer; indoor 
use 
35 3 3 sweet >20x/day safer; flavors 
19 4 1 menthol 3-10x/day safer; trendy 
35 3,4   6  sweet 10-20x/day safer; flavors 
25  1  1.5 menthol  >20x/day trendy 
18 4 3 menthol >20x/day trendy 
*Devices: 1 = first generation, 2 = second generation, 3 = third generation, 4 = current generation 
**Frequency: Sessions (x)= five minutes or less of ENDS use.  
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CHAPTER IV 
DISCUSSION 
 
Research Question 1: Are there similarities between acoustic measures of ENDS users 
and smokers? 
Results indicated that no significant relation was observed between acoustic 
measures obtained from smokers and ENDS users; however, due to small sample size, 
findings were also compared to norms for age and gender. When acoustic measures of 
smokers and ENDS users were compared to norms, results revealed similarities in one 
acoustic measure of ENDS users and smokers. Both showed raised shimmer percent in a 
majority of participants. Increased shimmer percent is indicative of vocal pathologies, 
such as altered tissue due to chronic irritation. This finding is consistent with prior 
research on acoustic measures in smokers (Banjara et al., 2011; Damborenea et al., 1999). 
Irritation and epithelial changes resulting from exposure to irritants and cytotoxic 
compounds may be responsible for the observed increase in shimmer percent in ENDS 
users (Buron et al., 2009; U.S. EPA, 2003; Arts et al., 2004; Farsalinos et al., 2013; 
Rowell & Taran, 2015).  
When compared to norms, no notable difference was observed in fundamental 
frequency and jitter values. This finding is not consistent with prior research on acoustic 
measures in smokers (Banjara et al., 2011; Damborenea et al., 1999).  Fundamental 
frequency changes due to smoking are attributed to increased mass due to swelling and 
are most frequently observed in females rather than males (Banjara et al., 2011; 
Damborenea et al., 1999; Gilbert & Weismer, 1974). This is likely due to females having 
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a smaller range of what is perceptually “normal” pitch as compared to males.   It is likely 
that the female sample size in both the ENDS and smoker groups in the present study was 
too limited to accurately investigate whether a comparison exists with regard to a 
reduction in F0.  
Research Question 2: Are there similarities in the vibratory characteristics, including 
mucosal wave, of ENDS users as compared to smokers? 
Results indicate that there are similarities in the mucosal wave and vocal fold 
vibratory characteristics of ENDS users and cigarette smokers.  In the present study, a 
significant relationship was found between abnormal mucosal wave and ENDS use. A 
marginally significant relationship was also found between abnormal wave and cigarette 
smoking. As the mucosal wave is caused by movement of the mucosal cover and may be 
reduced when the mucosal cover is altered, this finding appears to be consistent with 
prior studies that have found thickened mucosal cover in smokers (Banjara et al., 2011).  
It is speculated that abnormal mucosal wave in ENDS users in the present study may be 
due to similar changes in mucosal cover caused by chronic irritation due to inhalation of 
ENDS aerosol.  
Abnormal phase closure showed a significant relationship in both ENDS users 
and smokers as compared to nonsmokers in the present study. Among abnormal phase 
closure, the most common form noted in both ENDS users and smokers was phase 
closure with closed phase predominating. Phase closure with closed phase predominating 
may be caused by hyperfunction of laryngeal structures in response to irritation or 
swelling, as well as tissue changes, such as edema or the presence of lesions causing 
abnormalities in phase closure. In the present study, abnormal phase closure was 
 
 
60 
frequently associated with increased bilateral or unilateral edema, especially in ENDS 
users.  This may be the result of tissue changes caused by chronic irritation from ENDS 
aerosol similar to the tissue changes caused by chronic irritation from cigarette smoke 
(Salturk et al., 2015; Sataloff, 2005). 
In the current study, a marginally significant relationship was found between 
abnormal phase symmetry and both ENDS use and smoking. This relationship between 
abnormal phase symmetry and smoking is consistent with prior research, which 
associated abnormal phase symmetry with the presence of vocal fold edema (Banjara et 
al., 2011; Awan & Morrow, 2008). Abnormal phase symmetry in ENDS users may be 
attributed to edematous vocal folds as well, or to other tissue changes that have caused 
the vocal folds to have different mechanical properties. 
A marginally significant relationship was found in the present study between 
abnormal regularity and both ENDS use and smoking. This finding supports prior 
research on the effect of smoking on vocal fold vibration (Banjara et al., 2011; Awan & 
Morrow, 2008). The most frequent abnormal regularity in both groups was frequent 
inconsistency of cycles observed followed by inconsistency in the type of phase closure 
observed. As with asymmetry of phase, abnormality in regularity is indicative of 
differences between the mechanical properties of the two vocal folds. Vocal folds that 
have similar mechanical properties vibrate as mirror images of one another with 
observable cycle and phase closure consistency.  This abnormal finding reflects probable 
changes in vocal fold tissue of ENDS users, which may be a result of chronic irritation 
from toxins present in ENDS aerosol (Buron et al., 2009; U.S. EPA, 2003; Arts et al., 
2004; Farsalinos et al., 2013; Rowell & Taran, 2015).  
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In the current study, no significant relationship was observed between abnormal 
glottal closure and smoking or ENDS use. Earlier studies have mixed results regarding 
the effect of smoking on glottal closure. Banjara et al. (2011) found no significant 
difference between abnormal glottal gap findings between smoking and nonsmoking 
groups; however, Awan and Morrow (2007) found a significant difference, attributing 
observed differences in glottal closure to irritation of the arytenoid cartilages caused by 
smoking. The most frequently occuring glottal closure patterns for both ENDS and 
smoker groups was posterior gap followed by variable closure patterns. Posterior gap is a 
normal closure pattern. Variable closure patterns in ENDS users may be due to chronic 
irritation from ENDS aerosol altering the mechanical properties of the vocal folds.  
No significant relationship was found in the present study between abnormal 
amplitude and ENDS or cigarette use. Additionally, this study found no significant 
relationship between abnormal vertical level and chronic ENDS aerosol or cigarette 
smoke exposure. Finally, no significant relationship was found between abnormal 
supraglottic activity and the smoker group. Prior research on supraglottic activity in 
smokers is consistent with the present finding in smokers. Similarly, no significant 
relationship was found between ENDS use and abnormal supraglottic activity; however, a 
pattern of both static and dynamic supraglottic activity apparently unrelated to gag 
response was observed in ENDS users. This supraglottic activity was consistent with 
observations of supraglottic edema. Abnormal supraglottic activity may be due to 
compensation of laryngeal structures in response to edematous and irritated vocal folds.  
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Research Question 3: Are there similarities in the visual appearance of the vocal folds of 
ENDS users as compared to smokers? 
Results indicated that there are similarities in the visual appearance of the vocal 
folds of ENDS users and cigarette smokers, including abnormal vocal fold edge contour, 
varices, edema, and discoloration.  In the current study, a significant relationship was 
found between abnormal vocal fold edge contour and ENDS use when compared to 
nonsmokers. Abnormal free edge may be the result of microscopic tissue changes 
following chronic irritation or edema, or due to the presence of lesions. Abnormal free 
edge contour was evident though not significant in smokers as compared to nonsmokers. 
This finding is consistent with prior research on the effect of smoking on the larynx 
(Banjara et al., 2011; Awan & Morrow, 2008). Banjara et al. (2011) suggested that 
abnormal free edge findings in smokers is caused by chronic irritation of the vocal folds 
resulting in histological changes in vocal fold epithelium as described by Sataloff (2005). 
Salturk et al. (2015) discovered epithelial responses, including hyperplasia and 
metaplasia, evident in the vocal folds of ENDS users. The observed changes in vocal fold 
edge contour in ENDS users may be the result of similar alterations in vocal fold 
epithelium caused by chronic irritation from ENDS aerosol. 
In the present study, a significant relationship was observed between vocal fold 
varices and both ENDS use and smoking. The appearance of vascularity is characterized 
by capillary dilation or leakage, or thin red lines/veins on the vocal folds. Varices is 
known to accompany edema and is caused by irritation, including smoking and chemical 
exposure (Banjara et al., 2014). The current study’s finding of a significant relationship 
between varices and smoking is consistent with prior studies (Banjara et al., 2014). It 
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may be that the presence of vascularity in the vocal folds of ENDS users is also caused 
by chronic irritation due to exposure to mucous membrane and epithelial irritants within 
e-liquids and aerosol (Callahan-Lyon, 2014; Buron et al., 2009; U.S. EPA, 2003; Arts et 
al., 2004; Farsalinos et al., 2013; Rowell & Taran, 2015).  
Abnormal vocal fold edema showed a highly significant relationship in ENDS 
users as compared to nonsmokers. A significant relationship was also found between the 
presence of abnormal edema and smoking as compared to nonsmokers. The most 
frequently observed vocal fold edema was the appearance of unilateral and bilateral 
edema in the superficial lamina propria as well as the epithelium of ENDS users and 
smokers. This edema was observed to cause reduced movement of the mucosal wave, as 
well as to cause tissue within Reinke’s space to become more pliable and vibrate 
differently (see Figure 1.7). Reinke’s edema is accumulation of fluid or swelling in 
Reinke’s space due to chronic irritation and is highly correlated with chronic smoking 
(Jain et al., 2009). The presence of possible Reinke’s edema in ENDS users in the present 
study suggests that effects of ENDS aerosol on the tissue of the superficial lamina propria 
are similar to that of cigarette smoke. Of note, one ENDS participant with significant 
vocal fold edema presented with audible inhalation consistent with stridor and was 
referred to an otolaryngologist. Stridor is the involuntary production of noise upon 
inhalation and is a symptom of airway obstruction.  
The present study found a significant relationship between vocal fold 
discoloration and smoking. This finding is consistent with a prior study that found 
increased discoloration of laryngeal structures in smokers (Awan & Morrow, 2008). 
Vocal fold discoloration was evident though not significant in ENDS users.  A healthy 
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mucosal cover gives the vocal folds their pearl-white appearance. Vocal fold 
discoloration indicates changes in the tissue of the mucosal cover, consisting of the 
epithelium and superficial lamina propria or Reinke’s space. Swelling, irritation, 
dehydration, and trauma to this area may cause vocal fold discoloration. It may be that 
the discoloration evident in the vocal folds of ENDS users is due to dehydration, 
swelling, or irritation, similarly to the effect of cigarette smoke on the mucosal cover. 
Although ENDS aerosol is not produced by combustion as is cigarette smoke, toxins 
within ENDS aerosol have known irritative and dehydrating qualities (Callahan-Lyon, 
2014; Buron et al., 2009; U.S. EPA, 2003; Arts et al., 2004; Farsalinos et al., 2013; 
Rowell & Taran, 2015). 
Research Question 4: Are there similarities in the visual appearance of laryngeal 
structures of ENDS users as compared to smokers? 
The present study found a marginally significant increase in the presence of 
ventricular fold erythema in smokers as compared to nonsmokers. This finding is 
consistent with prior research that showed a significant increase in the presence of 
ventricular fold erythema in smokers as compared to nonsmokers (Banjara et al., 2011). 
No significant relationship was found between ventricular fold erythema and ENDS use; 
however, due to the small sample size of this study, it remains possible that a relationship 
may be found in studies with a larger sample.   
 In the current study, no significant relationship was observed between smoking or 
ENDS use and arytenoid erythema or arytenoid edema; however, past studies have found 
a significant relationship between smoking and arytenoid edema (Awan & Morrow, 
2007). This discrepancy is likely due to the small sample size of this study.  Additionally, 
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no significant relationship was found between smoking or ENDS use and vocal fold 
mucus; however, a pattern of of thick, white mucus was observed on three of seven 
ENDS users, which was not observed on the vocal folds of smokers and nonsmokers. 
Thick, opaque mucus may be caused by vocal fold tissue dehydration, irritation, or other 
vocal pathology (Hsiung, 2004; Bonilha, White, Kuckhahn, Gerlach & Deliyski, 2012). 
The toxins within ENDS aerosol have known irritative and dehydrating qualities; 
therefore, the presence of thick, white mucus on the vocal folds of ENDS users could be 
indicative of a vocal pathology. More research is necessary to be conclusive in this area.  
Conclusion 
  The purpose of the present study was to compare the laryngeal anatomy and 
physiology of ENDS users, smokers, and nonsmokers to determine whether similarities 
exist in the effect of ENDS aerosol as compared to cigarette smoke. In spite of the small 
sample size of this study, a pattern of similar changes in the appearance and function of 
the laryngeal anatomy was observed in ENDS users and smokers. These preliminary 
results suggest similarities may exist between the effect of ENDS use and smoking on the 
vocal folds; however, studies of much larger sample size are required to truly evaluate 
effects of ENDS on the vocal folds and make definitive determinations of safety. There 
have been anecdotal suggestions by ENDS companies that ENDS is a safer alternative to 
smoking. While this may be the case, based on seminal findings of this study, it may be 
beneficial for individuals to exercise caution in ENDS use as they would with cigarette 
use.   
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Limitations and Future Research 
 The present study has the following limitations. First, the sample size of each 
group was very small, despite a concerted effort to find greater numbers of participants. 
Recruiting participants for the ENDS group with no history of prior cigarette or other 
tobacco use within five years prior to data collection proved difficult. Many participants 
were excluded due to occasional cigarette or marijuana use. Second, the nonsmoking 
group primarily consisted of college students, which may present a confounding variable. 
Many college students are known to engage in behaviors and experiences that negatively 
affect the health and hygiene of the larynx, including academic stress, and poor nutrition, 
hydration, and sleep habits. Further studies should consider including specific questions 
regarding these behaviors on screening questionnaires.  
 Third, participants were not grouped by device type, frequency of use, battery 
voltage, or e-liquids used. Participants were frequently unable to determine battery 
voltage in order to provide information on the questionnaire. Due to the fact that research 
indicates these variables may impact the toxicity of ENDS, further research should 
control for these variables. Unfortunately, until ENDS are regulated and standardized, 
controlling for these variables would require testing of each device and e-liquids used 
rather than reliance on labeling by ENDS companies.  
 Fourth, participants were unable to provide details on the length of time or 
number of inhalations per vaping session with confidence, and thus, frequency was often 
determined by the number of sessions per day rather than number of inhalations. Future 
research should include an operational definition for frequency of use rather than 
depending on subjective determination by the individual participant.  
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 Finally, this study obtained videostroboscopic data using a rigid 
strobolaryngoscope. Studies have shown that the type of laryngoscope used may impact 
the amount of supraglottic activity observed on videostroboscopy. As participants did not 
receive numbing spray to reduce gag reflex, it is difficult to determine whether 
supraglottic activity observed is a result of cigarette or ENDS use, or whether it is due to 
an activated gag reflex. Future studies should consider the use of a rhinolaryngoscope in 
videostroboscopy, as evidence shows this scope is less likely to activate a gag reflex.   
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Appendix A 
Informed consent 
 
 
    
Informed Consent 
My name is Hilary Sample.  I am a graduate student at Cleveland State University in the speech and hearing 
program. I am requesting your participation in a research study.  If you have any questions, please feel free to contact 
my advisor, Dr. Violet Cox. She can be contacted by phone at (216) 687-6909 or by email at v.cox@csuohio.edu.  
The study aims to visually describe the structures of the larynx of individuals who use electronic nicotine 
delivery systems versus smokers and non-users.  If you decide to participate in this study, you will be asked to do three 
things: complete a questionnaire; complete assessment using the Visi-Pitch IV; and complete assessment using 
videostroboscopy. With the Visi-Pitch IV, you will be asked to say “ah” into a microphone for about five seconds in 
a natural voice. Your larynx will then be assessed for two to three minutes using videostroboscopy. During 
videostroboscopic evaluation, you will be asked to open your mouth and stick out your tongue. Gauze will be used to 
gently hold your tongue. A rigid endoscope, which is similar to a tongue depressor in feel and placement, will be 
inserted into your mouth to the back of the tongue. You will be asked to say the vowels “ah” and “ee” at differing 
pitches. The examination is not painful, but there is a possibility that you may gag because of the placement of the 
scope. If the gag continues, the procedure will end. The total time involved for the entire process is less than one hour.  
To participate, you must be between 18 and 35 years of age.   
Risks associated with participation are considered to be minimal.  Such risks are largely limited to 
compromised confidentiality.  To minimize such risks, all research documents will be secured in a locked file cabinet 
in Dr. Violet Cox’s office at Cleveland State University, and in the password protected hard drives of the Visi-pitch 
IV and videostroboscopy in the CSU Voice and Swallowing Lab in room 211.   You may withdraw from this study at 
any time without any consequence whatsoever.  Only summary results may be published, presented or used for 
instruction.  No personal identifiers will be included in such data.  You will be given $10 for participating in the study 
upon arrival to the voice lab; however, there are no other direct benefits available to you as a participant in this research. 
A copy of this Informed Consent will be provided to you for your records. 
Please read the following: “I understand that if I have any questions about my rights as a research subject, 
I can contact the Cleveland State University Institutional Review Board at (216) 687-3630.” 
Your signature below means that you understand the contents of this document.  You also are at least 18 years 
of age.  Finally, you voluntarily consent to participate in this research study.   
 
_________________________________________   _____________________ 
Signature        Date 
_________________________________________ 
Name (Printed) 
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Appendix B 
Questionnaire 
 
 
 
 
Screening Questionnaire for Research Participants 
Name: ________   Birthday: _______    Gender: _______   Date: ______________  
Please check the appropriate box(es) for each question:  
1. Have you had a history/diagnosis of any of the following? (check all that apply) 
         Acid Reflux   Polyps, nodules, contact ulcers    Asthma or allergies   Other pathologies of throat or vocal cords 
         ___________________________________ 
2. Have you been sick in the last two weeks with a head cold or upper respiratory infection?   YES    NO 
3. Do you frequently overuse your voice (yelling/screaming/talking over noise)?   YES     NO 
4. Which of the following have you ever used at least 2x daily, 7 days/week for at least one year?  
  ENDS: juul, e-cig, vape, mods, pods.     Cigarettes        Other tobacco/marijuana: _______     None   
5. Which of the following are you currently using at least 2x daily, 7 days/week for at least one year? 
  ENDS: juul, e-cig, vape, mods, pods.     Cigarettes        Other tobacco/marijuana: _______     None   
6. If you smoke: have you vaped within the past five years?   YES     NO 
7. If you smoke: for how many years have you smoked? ____________  
8. If you smoke: what type/brand do you smoke? ______________________ 
9. If you smoke: how frequently do you smoke?  
  <3x per day    3-10x per day    10-20x per day    Other: _____________________ 
10. If you vape: for how many years have you vaped?  _______________ 
11. If you vape: have you smoked within the past five years?   YES     NO 
12. If you vape: what devices do you use? (select all that apply) 
❏ Cig-a-like (same size as cigarette - disposable) 
❏ Rechargeable cigalike (same size as cigarette – rechargeable) 
❏ Vape pens/Mods (large/customizable batteries, advanced atomizers, refillable)  
❏ Pods (less vape, rechargeable, e.g., JUUL, Suorin Drop, myblu) 
13. What is the brand of your device? ______________ 
14. What is the voltage of your device? _____________ 
15. Is your device:   variable voltage or   temperature controlled? (check one) 
16. If you vape: how frequently do you vape? 
  more than 20x/day      10-20x/day     3-10x per day       Other: _________________ 
17. If you vape: what nicotine strength do you use? (check box and write amount) 
  Low ___________    Medium _________    High ___________    No Nicotine 
18. If you vape, what flavor(s) do you use? (Select all that apply) 
  Fruit or candy(sweet)    Tobacco    Menthol    Mint   Other: ______________ 
19. If you have used ENDS daily, what factors made you want to start?  
  ENDS are safer than cigarettes    Trendy/popular    Flavors   
  To quit smoking                        Indoor use          Other: ___________ 
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Appendix C 
Acoustic Analysis Participant Instructions 
 
 
 
 
 
 
 
Visi-pitch IV Instuctions 
 
“Please stand in front of the machine with the microphone about two inches from your mouth, 
like this (demonstrate). When I press record, say “ah” in a natural voice for 5 seconds, at which 
time I will stop the recording.”  
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Appendix D 
Videostroboscopy Participant Instruction 
 
 
 
 
 
 
Videostroboscopy Instructions: 
 
“Please sit in this examination chair. With your bottom far back in the chair, bring your shoulders 
forward and lift your chin. Now, open your mouth wide and stick out your tongue. I’m going to 
hold your tongue gently with gauze while you say “ah”. Now say “ee” in a natural voice for five 
seconds.  And now say “ee” in a high pitch and sustain for 5 seconds. Now say “ee” in a low 
pitch and sustain for five seconds. Now say “ee” in a low pitch and glide up to a high pitch. And 
finally, just breath normally for a few breaths.” 
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Appendix E  
Table of Acoustic Norms 
 
 
 
 
Acoustic 
Parameters 
 
Females (ages 18-39) 
 
Males (ages 18-39) 
Mean  SD 
 
Mean SD 
Fundamental 
Frequency 
(Hz) 
214.39 
 
26.76 
 
106.414 
 
13.29 
Jitter  
(%) 
0.82% 0.28% 1.41% 0.32% 
Shimmer 
(%) 
1.59% 0.68% 2.14% 0.63% 
Appendix E: Acoustic norms for 18-39 year olds by gender  
(From: Schaefer et al. 2008) 
